HIGHLIGHTS
- who: Wenchao Yang from the University of Kansas Medical Center, United States have published the research: Comparison of Efficacy and Safety Between Immunotherapy and Docetaxel Monotherapy in NSCLC Patients, in the Journal: (JOURNAL)
- what: In this study, randomized controlled trials (RCTs) of ICIs and docetaxel monotherapy in the treatment of NSCLC were searched and efficacy and safety were evaluated by meta-analysis. If the heterogeneity test result I2 is less than 50%, it means that there is no statistical heterogeneity among the research results, and the fixed effect model is used; If the heterogeneity test . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.